1Bernstein JJ, Woodard CA. Glioblastoma cells do not intravasate into blood vessels[J]. Neurosurgery, 1995, 36:124-132.
2Burger PC, Heinz ER, Shibata T, et al. Topographic anatomy and CT correlations in untreated glioblastoma multiforme [J]. J Neurosurg,1989, 68: 698-704.
3Silbergeld DL, Chicoine MR.Isolation and characterization of human malignant glioma cells from histologically normal brain [J]. J Neurosurg, 1997, 86:525-531.
4Chicoine MR, Silbergeld DL. Assessment of brain tumor cell motility in vivo[J]. J Neurosurg, 1995, 82:615-622.
5Letourneau PC, Condic ML, Snow DM. Interactions of developing neurons with the extracellular matrix [J]. J Neurosci, 1994, 14:915-928.
6Giese A, Loo MA, Norman SA, et al. Contrasting migratory response of astrocytoma cells totenascin mediated by different integrins [J]. J cell Sci, 1996, 109: 2161-2168.
7Hess KR, Broglio KR, Bondy ML. Adult Glioma Incidence Trends in the United States, 1977-2000 [J]. Cancer, 2004, 101: 2293-99.
8Plate KH, Breier G, Risau W. Molecular mechanisms of developmental and tumor angiogenesis [J]. Brain Pathol, 1994, 4:207-218.
9Wesseling P, van der laak JA, de leeuw H, et al. Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. Computer-assisted image analysis of whole tumor sections[J]. J Neurosurg, 1994, 81: 902-909.
10Holash J, Maisonpierre PC, Compton D, et al. Vessel cooption,regression, and growth in tumors mediated by angiopoietins and VEGF[J]. Science, 1999, 284: 1994-1998.
8Risau W. Mechanisms of angiogenesis[J]. Nature, 1997, 386(6626): 671-674.
9Gille J. Antiangiogenic cancer therapies get their act together: current developments and future prospects of growth factor- and growth factor receptor-targeted approaches[J]. Exp Dermatol, 2006, 15(3): 175-186.
10Hu CC, Ke YQ, Sun XL, et al. Human mesenchymal stem cells-like cells as cellular vehicles for delivery of immunotoxin in vitro [J]. Biotechnol Lett, 2009, 31(2): 181-189.
